Physician profile
Mark Walsh
NPI 1144376724
$3,185.85
in general payments reported to CMS, 2019-2025
14 companies · $829 in 2025
The $829 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $60.00 · 2021: $177 · 2022: $309 · 2023: $656 · 2024: $756 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,241.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,417.02 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Davol INC. | $442.20 | 2022-2023 | Phasix Mesh |
| Sientra, INC. | $373.13 | 2019 | |
| Kerecis Limited | $193.27 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Becton, Dickinson and Company | $154.72 | 2021 | |
| Baxter Healthcare | $119.45 | 2025 | |
| Allergan, INC. | $89.66 | 2022 | |
| Aroa Biosurgery Incorporated | $85.55 | 2019-2020 | |
| Motiva USA, LLC | $80.00 | 2024 | |
| Galderma Laboratories, L.P. | $74.31 | 2022-2025 | |
| Mentor Worldwide LLC | $65.92 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Axogen | $39.41 | 2023 | Avance Nerve Graft |
| Heron Therapeutics, INC. | $26.33 | 2024 | Zynrelef |
| Solventum Corporation | $24.88 | 2024 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.